Cardiovascular diseases are leading cause of morbidity and mortality globally. Biomarkers are generally used as an indicator forparticular diseases such as rheumatic and congenital heart diseases and cardiac arrhythmia. Cardiac biomarkers are measurable and quantifiable biological parameters. These are specifically used to check the presence or severity of cardiovascular diseases. ... Read more
According to a new report Global Cardiac Biomarkers Testing Market, published by KBV research, The Global Cardiac Biomarkers Testing Market size is expected to reach $16.2 billion by 2025, rising at a market growth of 11.4% CAGR during the forecast period.
The North America market dominated the Global Creatine Kinase (CK-MB) Market by Region in 2018, growing at a CAGR of 9.9 % during the forecast period. The Europe market is expected to witness a CAGR of 10.3% during (2019- ... Read more
The Cardiac Biomarkers Market continues to witness remarkable growth, thanks to relentless innovations that are revolutionizing cardiovascular disease diagnosis and management. With technological advancements and research breakthroughs, cardiac biomarkers have become essential tools in the hands of healthcare providers. This blog delves into some of the groundbreaking innovations driving the growth of the Cardiac Biomarkers Market and shaping the future of heart healthcare.
In the realm of modern medicine, cardiac biomarkers have emerged as crucial tools in diagnosing and managing heart-related conditions. These biomarkers are specific proteins or molecules released into the bloodstream in response to heart injury or stress. In this brief blog, we'll explore the significance of cardiac biomarkers, their role in assessing heart ... Read more
Cardiac biomarkers are biochemical indicators that are released into blood circulation upon injury or damage to cardiac muscles. They are used for diagnosis of conditions such as myocardial infarction and congestive heart failure. Cardiac troponin, Creatine Kinase-MB (CK-MB), myoglobin, heart-type fatty acid binding protein (H-FABP), and ischemia modified albumin (IMA) are some of the commonly used cardiac biomarkers. The increasing incidences of cardiovascular diseases has boosted the ... Read more
Cardiovascular diseases are a leading cause of morbidity and mortality worldwide. As our understanding of heart diseases has improved, so has our ability to accurately diagnose and manage these conditions. Cardiac biomarkers play a key role in modern cardiology by providing valuable information to clinicians. This article discusses some commonly used cardiac biomarkers and how they aid in the diagnosis and management of heart ... Read more
